Pharmafile Logo
Pharmafocus logo
Advanced Search
Researcher and patient

Patient involvement ‘would improve medicines R&D’

January 15, 2016
Medical Communications, Research and Development EUPATI, Patient and Public Involvement, R&D

A new study has revealed a belief among pharma industry executives that greater involvement of patients and the public could …

News

Wave Healthcare Communications – Four predictions for med ed in 2016

January 14, 2016
Medical Communications medical education

These are some of the trends Wave foresees in the forthcoming year: Integration We predict there will be a greater …

Feature
Thought Leadership
FDA

FDA says no to BioMarin’s Duchenne Muscular Dystrophy drug

January 14, 2016
Medical Communications, Sales and Marketing BioMarin, Duchenne Muscular Dystrophy, FDA, Kyndrisa, drisapersen

The FDA has rejected BioMarin’s Duchenne Muscular Dystrophy (DMD) drug Kyndrisa, saying there was not enough evidence that the drug …

News
Hospira logo

Pfizer may sell off Hospira unit for $2 billion

January 14, 2016
Manufacturing and Production, Medical Communications, Sales and Marketing Hospira, Pfizer, injectables, pumps

Pfizer is reportedly considering selling Hospira’s infusion pump business for around $2 billion, having acquired the injectable drugs and infusion …

News
Gavel

US Federal Trade Commission clamps down on pharma ‘pay to delay’ deals

January 14, 2016
Manufacturing and Production, Sales and Marketing Pay to delay, US Supreme Court, antitrust laws, federal trade commission, generic competition, generics, patents, pay for delay

Pharma companies were able to negotiate far fewer so-called ‘pay to delay’ cases as a strategy to stave off generic …

News
Ninlaro

Takeda in myeloma research drive

January 14, 2016
Medical Communications, Research and Development Ninlaro, Phase II, Takeda, Takeda oncology, eric low, ixazomib, multiple myeloma, myeloma

Takeda is funding the research charity Myeloma UK to run a Phase II study of its multiple myeloma treatment Ninlaro, …

News
Chemotherapy

A brighter future for the Cancer Drugs Fund?

January 14, 2016
Sales and Marketing Cancer Drugs Fund, NHS England, NICE, Prostate Cancer UK

In November 2015, NICE and NHS England announced proposed changes to the operation of the Cancer Drugs Fund. This is …

Feature
Illumina building

Illumina forms spin-off to develop cancer detection test

January 14, 2016
Research and Development Cancer, Illumina, cancer detection, gene sequencing, liquid biospy, oncology

Global gene sequencing company Illumina has won over $100 million in investment from high-profile investors, to create a company “to …

News
Baxalta logo

Baxalta’s Enbrel biosimilar measures up in late-stage study

January 13, 2016
Research and Development Amgen, Baxalta, Enbrel, Pfizer, biosimilar, etanercept, rheumatoid arthritis

Having emerged from its mega-merger deal with Shire, Baxalta is back on its drug development day job – and has …

News
Keytruda image

BioLineRx to test lead candidate with MSD’s Keytruda in pancreatic cancer

January 13, 2016
Research and Development MSD, immunotherapy, keytruda, pembrolizumab

Israeli biopharma company BioLineRx has announced a collaboration with MSD on a Phase II study investigating its lead oncology candidate, …

News
Obama_SOTU

Big pharma joins President Obama’s cancer ‘moonshot’

January 13, 2016
Research and Development Amgen, Cancer, Celgene, National Immunotherapy Coalition, President Barack Obama, US, moonshot

Celgene and Amgen are among the large biopharma companies that have agreed to join the National Immunotherapy Coalition (NIC), a …

News

Cell and Gene Therapy World: PCI Pharma Services expert to present on cold chain challenges

January 13, 2016
Medical Communications

Leading pharmaceutical provider PCI Pharma Services will bring its expertise to the stage at Cell and Gene Therapy World (January …

News
Press release
dr_robert_califf_image_via_duke_university_school_of_medicine

Senate panel approves Dr Robert Califf as FDA commissioner

January 13, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Robert Califf, FDA, FDA commissioner, Senate

A senate panel has approved president Obama’s nominee Dr Robert Califf to lead the FDA by a clear majority, although …

Appointment
Takeda reception

Takeda and enGene partner to develop gastro drugs

January 13, 2016
Research and Development Takeda

Takeda is teaming up with Canadian biotech enGene to develop novel therapies for specialty gastrointestinal (GI) diseases, using enGene’s ‘gene …

News
medimmune_logo_on_building

MedImmune and UCSF team up to research RAI treatments

January 13, 2016
Research and Development MedImmune, Precision Medicine, University of California San Francisco, autoimmunity

AstraZeneca’s biologics R&D arm MedImmune and the University of California, San Francisco (UCSF) have announced a new research collaboration focused …

News
MSD logo

MSD to acquire Scottish firm IOmet Pharma

January 12, 2016
Research and Development, Sales and Marketing IOMet Pharma, MSD, Merck, Scotland, acquisitions, immuno-oncology, mergers, oncology

US pharma company MSD is to buy Edinburgh based IOMet Pharma to expand its existing R&D programme, exploring the development …

News
Eisai

Eisai submits new cancer combo to EMA for approval

January 12, 2016
Sales and Marketing Afinitor, EMA, Eisai, Lenvima, MAA, Novartis, everolimus, lenvatinib

Eisai has submitted a new Marketing Authorisation Application to the EMA for the combination of Lenvima and Novartis’ Afinitor for …

News
Jinarc

SMC approves first ever treatment for genetic kidney disease

January 12, 2016
Sales and Marketing Otsuka, SMC, Scottish Medicines Consortium, jinarc, kidney disease, tolvaptan

The Scottish Medicines Consortium (SMC) has approved Otsuka’s Jinarc for the treatment of the genetic kidney disease autosomal dominant polycystic …

News
Horsham

Former Novartis site to be developed into science park

January 12, 2016
Manufacturing and Production Employment, Jobs, Life science, Novartis, West Sussex, science park

Work has begun to transform a 20-acre site that formerly housed Novartis, in West Sussex, into a world renowned centre …

News
a

AstraZeneca and MedImmune in oncology research deals

January 12, 2016
Manufacturing and Production, Research and Development AstraZeneca, Incyte, MedImmune, Moderna Therapeutics

AstraZeneca and its biologics arm MedImmune are launching new agreements with partner companies, to develop new targets for cancer, and …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026